Aptevo Research and Development LLC
Records under this name other than the patents Aptevo Research and Development LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
Back to Aptevo Research and Development LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,239,949 | Oncofetal Antigen Binding Proteins and Related Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 10,202,452 | CD3 Binding Polypeptides Lapsed on the fee record Ended Feb 12, 2023 · High confidence | Lapsed on the fee record | Ended Feb 12, 2023 | High confidence |
| US 7,846,434 | Materials and Methods for Improved Immunoglycoproteins Lapsed on the fee record Ended Dec 7, 2022 · Medium confidence | Lapsed on the fee record | Ended Dec 7, 2022 | Medium confidence |
| US 10,143,748 | B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules Formerly held Lapsed on the fee record Ended Dec 4, 2022 · High confidence | Lapsed on the fee record | Ended Dec 4, 2022 | High confidence |
| US 7,829,084 | Binding Constructs and Methods for Use Thereof Lapsed on the fee record Ended Nov 9, 2022 · Medium confidence | Lapsed on the fee record | Ended Nov 9, 2022 | Medium confidence |
| US 8,853,366 | Binding Domain-Immunoglobulin Fusion Proteins Term ended Term ended Feb 12, 2022 · Medium confidence | Term ended | Term ended Feb 12, 2022 | Medium confidence |
| US 9,005,612 | Binding Domain-Immunoglobulin Fusion Proteins Term ended Term ended Jan 17, 2022 · Medium confidence | Term ended | Term ended Jan 17, 2022 | Medium confidence |
| US 9,782,478 | Prostate-Specific Membrane Antigen Binding Proteins and Related Compositions and Methods Lapsed on the fee record Ended Oct 10, 2021 · High confidence | Lapsed on the fee record | Ended Oct 10, 2021 | High confidence |
| US 8,383,106 | Materials and Methods for Improved Immunoglycoproteins Lapsed on the fee record Ended Feb 26, 2021 · Medium confidence | Lapsed on the fee record | Ended Feb 26, 2021 | Medium confidence |
| US 9,493,564 | CD86 Antagonist Multi-Target Binding Proteins Lapsed on the fee record Ended Nov 15, 2020 · High confidence | Lapsed on the fee record | Ended Nov 15, 2020 | High confidence |